← Eichor
Study identifier: NCT06916507 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Condition: Parkinson's Disease  ·  Sponsor: AbbVie

PhaseN/A
Planned participants125
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective foscarbidopa/ foslevodopa is in treating German adult participants at initial stages of advanced Parkinson's disease under routine clinical practice. Foslevodopa/Foscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 125 adult participants who are prescribed Foslevodopa/Foscarbidopa by their doctors will be enrolled across approximately 20 sites in Germany. Participants will receive Foslevodopa/Foscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 12 months. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Medical Information Germany  ·  49 611 1720 1520  ·  medinfo.germany@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (17)

Universitaetsklinikum Heidelberg /ID# 274164Heidelberg, Baden-Wurttemberg, GermanyRecruiting
Universitaetsklinikum Tuebingen /ID# 275828Tübingen, Baden-Wurttemberg, GermanyRecruiting
Praxis Prof. Kassubek/Prof. Riecker /ID# 274165Ulm, Baden-Wurttemberg, GermanyRecruiting
Parkinson-Klinik Ortenau GmbH&Co KG /ID# 274161Wolfach, Baden-Wurttemberg, GermanyRecruiting
Universitaetsklinikum Erlangen /ID# 280831Erlangen, Bavaria, GermanyRecruiting
Klinikum Ingolstadt /ID# 280573Ingolstadt, Bavaria, GermanyRecruiting
Klinikum der Universitaet Muenchen Grosshadern /ID# 274168Munich, Bavaria, GermanyRecruiting
Klinikum Ernst von Bergmann /ID# 274176Potsdam, Brandenburg, GermanyRecruiting
Universitaetskliniken Giessen und Marburg /ID# 274224Marburg, Hesse, GermanyRecruiting
Knappschaftskrankenhaus Bottrop /ID# 274284Bottrop, North Rhine-Westphalia, GermanyRecruiting
Cellitinnen-NTC Neurologisches Therapiecentrum /ID# 277865Cologne, North Rhine-Westphalia, GermanyRecruiting
Klinikum Lippe Detmold /ID# 279451Detmold, North Rhine-Westphalia, GermanyRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06916507